Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
News | Radiation Therapy | October 03, 2016
September 29, 2016 — The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors...
News | Cardio-oncology | September 28, 2016
September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for...
News | Prostate Cancer | September 27, 2016
September 27, 2016 — For men with early stage, low-risk prostate cancer, hypofractionated radiation therapy (RT) offers...
News | Prostate Cancer | September 26, 2016
September 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three distinct...
News | Prostate Cancer | September 26, 2016
September 26, 2016 — For men with intermediate-risk prostate cancer, side effects at two years following radiation...
News | Radiation Therapy | September 07, 2016
September 7, 2016 — The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual...
News | Radiopharmaceuticals and Tracers | September 07, 2016
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...
News | Magnetic Resonance Imaging (MRI) | August 23, 2016
August 23, 2016 — A novel magnetic resonance imaging (MRI) method that detects low levels of zinc ion can help...
News | Prostate Cancer | August 16, 2016
August 16, 2016 — High-risk prostate cancer patients treated at hospitals with a high proportion of administered...
ExactVu micro-ultrasound system image courtesy of Exact Imaging.
News | Prostate Cancer | August 08, 2016
July 28, 2016 — Exact Imaging announced that The Journal of Urology has published the initial results supporting the...
Feature | Prostate Cancer | July 25, 2016
July 25, 2016 — The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004...
Images of prostate cells captured through photoacoustic imaging. Top: cancer cells that express the targeted cancer marker, PSMA; bottom: cells that lack PSMA. A research team led by Kent Nastiuk of Roswell Park Cancer Institute has published new evidence that this approach can be a useful tool in monitoring and selecting treatments for many cancers.
News | Prostate Cancer | July 15, 2016
While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary...
The figure shows a Gleason 3+4 prostate cancer (arrows) as identified on T2-weighted (A) and diffusion-weighted (B) MRI, F-18-choline PET (C), as well as PET/MRI (D).
News | Prostate Cancer | July 14, 2016
July 14, 2016 — Adding F-18-choline positron emission tomography (PET) to multi-parametric prostate magnetic resonance...
News | Prostate Cancer | July 13, 2016
July 13, 2016 — Overlake Medical Center, Bellevue, Wash., recently announced it is formally adopting a new standard of...
News | PET-CT | June 20, 2016
June 20, 2016 — Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at...
News | Prostate Cancer | June 17, 2016
June 17, 2016 — Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline positron emission tomography (...
Jeffrey Nix, M.D., left, and Soroush Rais-Bahrami, M.D., with the iSR’obotTM Mona Lisa , a new image guided device for diagnosing prostate cancer. Image courtesy of UAB News.
News | Biopsy Systems | June 09, 2016
June 9, 2016 — The University of Alabama at Birmingham (UAB) announced it is one of two beta sites in the United States...
News | PET-CT | June 07, 2016
June 7, 2016 — A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium...
Technology | Radiopharmaceuticals and Tracers | June 07, 2016
June 7, 2016 — Blue Earth Diagnostics Ltd. and Siemens’ PETNET Solutions Inc. announced the commercial availability of...
The image on the left is a magnetic resonance image (MRI) of a prostate enhanced with restriction spectrum imaging (RSI). Higher grade tumor is indicated by orange and yellow. The image on the right is a digitized section of the prostate with the tumors outlined with blue dotted lines. Image courtesy of UC San Diego Health.
News | Prostate Cancer | June 02, 2016
June 2, 2016 — Physicians have long used magnetic resonance imaging (MRI) to detect cancer, but a new study describes...
